Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (49) 49
science & technology (49) 49
humans (43) 43
male (38) 38
female (36) 36
middle aged (32) 32
adult (31) 31
hematology (29) 29
aged (25) 25
oncology (24) 24
prognosis (16) 16
adolescent (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
biological and medical sciences (12) 12
medical sciences (12) 12
treatment outcome (11) 11
chemotherapy (10) 10
disease-free survival (10) 10
hematologic and hematopoietic diseases (10) 10
kaplan-meier estimate (10) 10
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (10) 10
young adult (9) 9
recurrence (8) 8
risk factors (8) 8
abridged index medicus (7) 7
aged, 80 and over (7) 7
spain (7) 7
cancer (6) 6
care and treatment (6) 6
leukemia (6) 6
multivariate analysis (6) 6
remission induction (6) 6
vidarabine - analogs & derivatives (6) 6
analysis (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
cyclophosphamide - administration & dosage (5) 5
genetic aspects (5) 5
hematology, oncology and palliative medicine (5) 5
leukemia, myeloid, acute - genetics (5) 5
mitoxantrone - administration & dosage (5) 5
patients (5) 5
proportional hazards models (5) 5
retrospective studies (5) 5
rituximab (5) 5
stem cell transplantation (5) 5
time factors (5) 5
vidarabine - administration & dosage (5) 5
apparatus for making beverages (4) 4
coffee mills (4) 4
combined modality therapy (4) 4
dentistry (4) 4
domestic articles or appliances (4) 4
furniture (4) 4
human necessities (4) 4
immunohistochemistry (4) 4
kitchen equipment (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
leukemia, myeloid, acute - mortality (4) 4
lymphocytes b (4) 4
lymphoma (4) 4
medical research (4) 4
medicine, experimental (4) 4
multiple myeloma (4) 4
multiple myeloma - therapy (4) 4
myeloid leukemia (4) 4
neoplasm, residual (4) 4
original (4) 4
outcome (4) 4
prospective studies (4) 4
relapse (4) 4
research (4) 4
spice mills (4) 4
stem cells (4) 4
suction cleaners in general (4) 4
survival analysis (4) 4
survival rate (4) 4
transplantation (4) 4
vidarabine - adverse effects (4) 4
acute lymphatic leukemia (3) 3
acute lymphoblastic leukemia (3) 3
acute lymphocytic leukemia (3) 3
acute myeloid leukemia (3) 3
acute promyelocytic leukemia (3) 3
adults (3) 3
age factors (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
burkitt lymphoma - drug therapy (3) 3
central nervous system (3) 3
cohort studies (3) 3
cyclin-dependent kinase inhibitor p15 - genetics (3) 3
cyclophosphamide - adverse effects (3) 3
cytogenetic analysis (3) 3
dentistry, oral surgery & medicine (3) 3
diseases (3) 3
drug administration schedule (3) 3
feasibility studies (3) 3
follow-up studies (3) 3
gene deletion (3) 3
genetics & heredity (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
by Juan José Lahuerta and Maria Victoria Mateos and Joaquin Martínez-López and Laura Rosiñol and Anna Sureda and Javier de la Rubia and José García-Laraña and Rafael Martínez-Martínez and Miguel T. Hernández-García and Dolores Carrera and Joan Besalduch and Felipe de Arriba and José María Ribera and Lourdes Escoda and Belén Hernández-Ruiz and Javier García-Frade and Concepción Rivas-González and Adrían Alegre and Joan Bladé and Jesús F. San Miguel
Journal of clinical oncology, ISSN 0732-183X, 12/2008, Volume 26, Issue 35, pp. 5775 - 5782
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Prospective Studies | Multiple Myeloma - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Transplantation, Autologous | Treatment Outcome | Remission Induction | Spain | Stem Cell Transplantation | Disease-Free Survival | Multiple Myeloma - therapy | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Transplantation Conditioning | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy
by Díaz-Santa, Johana and Rodríguez-Romanos, Rocío and Osca, Gemma and Pratcorona, Marta and Garrido, Ana and Coll, Rosa and Moret, Carla and Escoda, Lourdes and Tormo, Mar and Heras, Inma and Arnan, Montse and Vives, Susanna and Salamero, Olga and Lloveras, Natàlia and Bargay, Joan and Sampol, Antònia and Cruz, David and Garcia, Antoni and Quiñones, Teresa and Esteve, Jordi and Sierra, Jorge and Gallardo, David and CETLAM Grp and on the behalf of CETLAM Group
Leukemia, ISSN 0887-6924, 2020, Volume 34, Issue 11, pp. 2925 - 2933
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Chemotherapy | Genetic aspects | Transferases | Genetic polymorphisms | Cancer | Myeloid leukemia | Leukemia | Multivariate analysis | Risk analysis | Gene polymorphism | Patients | Subgroups | Risk factors | Genotype & phenotype | Cytarabine | Cytogenetics | Acute myeloid leukemia | Neutropenia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia
by Francesc Bosch and Pau Abrisqueta and Neus Villamor and María José Terol and Eva González-Barca and Christelle Ferra and Marcos González Diaz and Eugenia Abella and Julio Delgado and Félix Carbonell and José Antonio García Marco and Lourdes Escoda and Secundino Ferrer and Encarnación Monzó and Yolanda González and Cristina Estany and Isidro Jarque and Olga Salamero and Ana Muntañola and Emili Montserrat
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4578 - 4584
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Mitoxantrone - administration & dosage | Humans | Middle Aged | Male | Vidarabine - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Adult | Female | Aged | Vidarabine - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition
by Jimenez, Isabel and Carabia, Julia and Bobillo, Sabela and Palacio, Carles and Abrisqueta, Pau and Pages, Carlota and Nieto, Juan C and Castellvi, Josep and Martinez-Ricarte, Francisco and Escoda, Lourdes and Perla, Cristobal and Cespedes Torrez, Dennis H and Boix, Joan and Purroy, Noelia and Puigdefabregas, Lluis and Seoane, Joan and Bosch, Francesc and Crespo, Marta
Journal of neuro-oncology, ISSN 0167-594X, 08/2020, Volume 149, Issue 1, pp. 13 - 25
Oncology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Flow cytometry | Animal models | Bioluminescence | Cell survival | Immune response | PD-1 protein | Immunomodulation | Central nervous system | Parenchyma | Cytotoxicity | Inflammation | B-cell receptor | Macrophages | Patients | Lymphoma | Nuclear transport | Blood-brain barrier | Lymphocytes B | Xenografts | Movement disorders | B-cell lymphoma | Index Medicus | Laboratory Investigation | BTK | PCNSL | Innate immune system | XPO1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
by Gutiérrez-García, Gonzalo and Cardesa-Salzmann, Teresa and Climent, Fina and González-Barca, Eva and Mercadal, Santiago and Mate, José L and Sancho, Juan M and Arenillas, Leonor and Serrano, Sergi and Escoda, Lourdes and Martínez, Salomé and Valera, Alexandra and Martínez, Antonio and Jares, Pedro and Pinyol, Magdalena and García-Herrera, Adriana and Martínez-Trillos, Alejandra and Giné, Eva and Villamor, Neus and Campo, Elías and Colomo, Luis and López-Guillermo, Armando and Grp Estudi Limfomes Catalunya and Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB) and for the Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
Blood, ISSN 0006-4971, 05/2011, Volume 117, Issue 18, pp. 4836 - 4843
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Immunohistochemistry | Prognosis | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Rituximab | Immunophenotyping | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Young Adult | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - therapy | Algorithms | Immunotherapy | Adolescent | Aged, 80 and over | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Aged | Lymphoma, Large B-Cell, Diffuse - genetics | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Copy number profiling of adult relapsed B‐cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms
by Ribera, Jordi and Zamora, Lurdes and Morgades, Mireia and Mallo, Mar and Solanes, Neus and Batlle, Montserrat and Vives, Susana and Granada, Isabel and Juncà, Jordi and Malinverni, Roberto and Genescà, Eulàlia and Guàrdia, Ramon and Mercadal, Santiago and Escoda, Lourdes and Martinez‐Lopez, Joaquín and Tormo, Mar and Esteve, Jordi and Pratcorona, Marta and Martinez‐Losada, Carmen and Solé, Francesc and Feliu, Evarist and Ribera, Josep‐Maria and Spanish PETHEMA Grp Spanish Soc He and Spanish PETHEMA Group and the Spanish Society of Hematology and for the Spanish PETHEMA Group and the Spanish Society of Hematology
Genes chromosomes & cancer, ISSN 1045-2257, 11/2017, Volume 56, Issue 11, pp. 810 - 820
Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Gene Duplication | Recurrence | Proto-Oncogene Proteins c-ets - genetics | Humans | Middle Aged | PAX5 Transcription Factor - genetics | Leukemia, B-Cell - pathology | Repressor Proteins - genetics | Male | Histone Demethylases - genetics | Tumor Suppressor Protein p53 - genetics | DNA Copy Number Variations | Ikaros Transcription Factor - genetics | Antigens, Nuclear - genetics | Cyclin-Dependent Kinase Inhibitor p18 - genetics | Leukemia, B-Cell - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Adult | Female | Ataxia Telangiectasia Mutated Proteins - genetics | Nuclear Proteins - genetics | Medical research | Analysis | Stem cells | Medicine, Experimental | Development and progression | Acute lymphocytic leukemia | Drug resistance | Tumor proteins | Cell proliferation | Multiplexing | Deregulation | Copy number | Leukemia | p53 Protein | Genes | Homeostasis | Single-nucleotide polymorphism | Pax5 protein | Alterations | Salvage | Pathways | Reproduction (copying) | Peripheral blood | Bone marrow | Evolution | Lesions | Acute lymphatic leukemia | Lymphatic leukemia | Gene expression | Patients | Lymphocytes B | Diagnostic systems | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Molecular profiling refines minimal residual disease‐based prognostic assessment in adults with Philadelphia chromosome‐negative B‐cell precursor acute lymphoblastic leukemia
by Ribera, Jordi and Zamora, Lurdes and Morgades, Mireia and Vives, Susana and Granada, Isabel and Montesinos, Pau and Gómez‐Seguí, Inés and Mercadal, Santiago and Guàrdia, Ramon and Nomdedeu, Josep and Pratcorona, Marta and Tormo, Mar and Martínez‐Lopez, Joaquín and Hernández‐Rivas, Jesús‐María and Ciudad, Juana and Orfao, Alberto and González‐Campos, José and Barba, Pere and Escoda, Lourdes and Esteve, Jordi and Genescà, Eulàlia and Solé, Francesc and Feliu, Evarist and Ribera, Josep‐Maria and Spanish PETHEMA Grp and Spanish Soc Hematology and Spanish Society of Hematology and Spanish PETHEMA Group and on behalf of the Spanish PETHEMA Group
Genes chromosomes & cancer, ISSN 1045-2257, 11/2019, Volume 58, Issue 11, pp. 815 - 819
Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Recurrence | Prognosis | Humans | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Male | Biomarkers, Tumor | Disease Progression | Ikaros Transcription Factor - genetics | Neoplasm, Residual | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Gene Deletion | Adolescent | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Adult | Female | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Ikaros Transcription Factor - metabolism | Philadelphia Chromosome | Relapse | Transplantation | Genetic aspects | Adults | Acute lymphocytic leukemia | Hematopoietic stem cells | Diseases | Cancer | Profiling | Acute lymphatic leukemia | Leukemia | Health risks | Minimal residual disease | Stem cell transplantation | Lymphatic leukemia | Hemopoiesis | Philadelphia chromosome | Lymphocytes B | Risk assessment | Stem cells | Adolescents | Chromosomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial
by Ribera, Josep-Maria and Ribera, Josep-Maria and Oriol, Albert and Oriol, Albert and Morgades, Mireia and Morgades, Mireia and Montesinos, Pau and Montesinos, Pau and Sarrà, Josep and Sarrà, Josep and González-Campos, José and González-Campos, José and Brunet, Salut and Brunet, Salut and Tormo, Mar and Tormo, Mar and Fernández-Abellán, Pascual and Fernández-Abellán, Pascual and Guàrdia, Ramon and Guàrdia, Ramon and Bernal, María-Teresa and Bernal, María-Teresa and Esteve, Jordi and Esteve, Jordi and Barba, Pere and Barba, Pere and Moreno, María-José and Moreno, María-José and Bermúdez, Arancha and Bermúdez, Arancha and Cladera, Antonia and Cladera, Antonia and Escoda, Lourdes and Escoda, Lourdes and García-Boyero, Raimundo and García-Boyero, Raimundo and Del Potro, Eloy and Del Potro, Eloy and Bergua, Juan and Bergua, Juan and Amigo, María-Luz and Amigo, María-Luz and Grande, Carlos and Grande, Carlos and Rabuñal, María-José and Rabuñal, María-José and Hernández-Rivas, Jesús-María and Hernández-Rivas, Jesús-María and Feliu, Evarist and Feliu, Evarist
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 15, pp. 1595 - 1604
Life Sciences & Biomedicine | Oncology | Science & Technology | Multivariate Analysis | Predictive Value of Tests | Age Factors | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Patient Selection | Neoplasm, Residual | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Flow Cytometry | Time Factors | Adult | Female | Maintenance Chemotherapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Philadelphia Chromosome | Genetic Predisposition to Disease | Consolidation Chemotherapy - mortality | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Logistic Models | Treatment Outcome | Spain | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Phenotype | Adolescent | Consolidation Chemotherapy - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication
by Francesc Bosch and Ana Ferrer and Neus Villamor and Marcos González and Javier Briones and Eva González-Barca and Eugenia Abella and Santiago Gardella and Lourdes Escoda and Elena Pérez-Ceballos and Antoni Asensi and Ma José Sayas and Llorenç Font and Albert Altés and Ana Muntañola and Paola Bertazzoni and María Rozman and Marta Aymerich and Eva Giné and Emili Montserrat
Clinical cancer research, ISSN 1078-0432, 01/2008, Volume 14, Issue 1, pp. 155 - 161
ZAP-70 | FCM | genes | Phase I-III Clinical Trials | Chronic Lymphocytic leukemia | Minimal residual disease | IgV | Leukemias and lymphomas | Hematologic, other | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Neoplasm, Residual - pathology | Cyclophosphamide - administration & dosage | Neoplasm, Residual - metabolism | Mitoxantrone - administration & dosage | Humans | Middle Aged | ZAP-70 Protein-Tyrosine Kinase - biosynthesis | Male | Cyclophosphamide - adverse effects | Female | Mitoxantrone - adverse effects | Vidarabine - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Vidarabine - analogs & derivatives | Remission Induction | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | L-Lactate Dehydrogenase - blood | ADP-ribosyl Cyclase 1 - biosynthesis | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Neoplasm, Residual - drug therapy | Survival Analysis | Immunoglobulin Variable Region - genetics | Vidarabine - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Immunoglobulin Heavy Chains - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients
by Ribera, Jordi and Granada, Isabel and Morgades, Mireia and Vives, Susana and Genescà, Eulàlia and González, Celia and Nomdedeu, Josep and Escoda, Lourdes and Montesinos, Pau and Mercadal, Santiago and Coll, Rosa and González‐Campos, José and Abella, Eugenia and Barba, Pere and Bermúdez, Arancha and Gil, Cristina and Tormo, Mar and Pedreño, María and Martínez‐Carballeira, Daniel and Hernández‐Rivas, Jesús‐María and Orfao, Alberto and Martínez‐López, Joaquín and Esteve, Jordi and Bravo, Pilar and Garcia‐Guiñon, Antoni and Debén, Guillermo and Moraleda, José M and Queizán, José A and Ortín, Xavier and Moreno, María J and Feliu, Evarist and Solé, Francesc and Ribera, Josep M and PETHEMA Grp and Spanish Soc Haematology and PETHEMA Group, Spanish Society of Haematology and the PETHEMA Group, Spanish Society of Haematology
British journal of haematology, ISSN 0007-1048, 07/2019, Volume 186, Issue 2, pp. 263 - 268
hypodiploidy | prognosis | acute lymphoblastic leukaemia | age | adults | Life Sciences & Biomedicine | Hematology | Science & Technology | Age Factors | Humans | Middle Aged | Male | Survival Rate | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Incidence | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Ploidies | Adolescent | Adult | Female | Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Retrospective Studies | Aged patients | Prognosis | Acute lymphatic leukemia | Lymphocytes B | Hypodiploidy | Precursors | Leukemia | Medical prognosis | Older people | Minimal residual disease | Adults | Geriatrics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma
by Jiménez‐Segura, Raquel and Granell, Miquel and Gironella, Mercè and Abella, Eugenia and García‐Guiñón, Antoni and Oriol, Albert and Cabezudo, Elena and Clapés, Victoria and Soler, Joan Alfons and Escoda, Lourdes and López-Pardo, Jordi and Fernández de Larrea, Carlos and Cibeira, Maria Teresa and Tovar, Natalia and Isola, Ignacio and Bladé, Joan and Rosiñol, Laura and GEMMAC and GEMMAC (Grup per l l'estudi del mieloma mútiple i l'amiloïdosi de Catalunya)
European journal of haematology, ISSN 0902-4441, 05/2019, Volume 102, Issue 5, pp. 389 - 394
plasmacytomas | multiple myeloma | pomalidomide | Life Sciences & Biomedicine | Hematology | Science & Technology | Medical research | Care and treatment | Relapse | Dexamethasone | Multiple myeloma | Medicine, Experimental | Diseases | Steroids | Urine | Survival | Patients | Medical prognosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights